Abstract:Pleckstrin homeolike domain, family A, member 1 (PHLDA1) is a multifunctional protein that plays diverse roles in A variety of biological processes, including cell death, and hence its altered expression has been found in different types of cancer. Although studies have shown a regulatory relationship between p53 and PHLDA1, the molecular mechanism is still unclear. Especially, the role of PHLDA1 in the process of apoptosis is still controversial. In this study, we found that the expression of PHLDA1 in human cervical cancer cell lines was correlated with the up-expression of p53 after treatment with apoptosis-inducing factors. Subsequently, the binding site and the binding effect of p53 on the promoter region of PHLDA1 were verified by our bioinformatics data analysis and luciferase reporter assay. Indeed, we used CRISPR-Cas9 to knockout the p53 gene in HeLa cells and further confirmed that p53 can bind to the promoter region of PHLDA1 gene, and then directly regulate the expression of PHLDA1 by recruiting P300 and CBP to change the acetylation and methylation levels in the promoter region. Finally, a series of gain–of–function experiments further confirmed that p53 re-expression in HeLa p53-/- cell can up-regulate the reduction of PHLDA1 caused by p53 knockout, and affect cell apoptosis and proliferation. Our study is the first to explore the regulatory mechanism of p53 on PHLDA1 by using the p53 gene knockout cell model, which further proves that PHLDA1 is a target-gene in p53-mediated apoptosis, and reveals the important role of PHLDA1 in cell fate determination.

PHLDA3 Impedes Somatic Cell Reprogramming by Activating Akt-GSK3β Pathway

Differential Effects of Akt Isoforms on Somatic Cell Reprogramming

p53 isoform Δ133p53 promotes efficiency of induced pluripotent stem cells and ensures genomic integrity during reprogramming

P53 Isoform Delta 133p53 Promotes Efficiency Of Induced Pluripotent Stem Cells And Ensures Genomic Integrity During Reprogramming

P53-Facilitated Mir-199A-3p Regulates Somatic Cell Reprogramming

Increase Developmental Plasticity Of Human Keratinocytes With Gene Suppression

Dppa3 expression is critical for generation of fully reprogrammed iPS cells and maintenance of Dlk1-Dio3 imprinting

PHLDA1 is a P53 target gene involved in P53-mediated cell apoptosis

Generation of Human-Induced Pluripotent Stem Cells in the Absence of Exogenous Sox2

Context‐Dependent Enhancement of Induced Pluripotent Stem Cell Reprogramming by Silencing Puma

The P53-Induced Lincrna-P21 Derails Somatic Cell Reprogramming by Sustaining H3K9me3 and CpG Methylation at Pluripotency Gene Promoters

P53 and Stem Cells: New Developments and New Concerns

Jmjd3 Inhibits Reprogramming by Upregulating Expression of INK4a/Arf and Targeting PHF20 for Ubiquitination

Mir-138 Promotes Induced Pluripotent Stem Cell Generation Through the Regulation of the P53 Signaling

p53 and stem cells: new developments and new concerns.

p18 inhibits reprogramming through inactivation of Cdk4/6

JAK-STAT3 and Somatic Cell Reprogramming.

Early inhibition of BRD4 facilitates iPSC reprogramming via accelerating rDNA dynamic expression

Prolyl Hydroxylase 3 Stabilizes the P53 Tumor Suppressor by Inhibiting the P53–mdm2 Interaction in a Hydroxylase-Independent Manner

The role of p53 in the transformation of induced pluripotent stem cells to tumor cells

AP-1 activity is a major barrier of human somatic cell reprogramming